pI: 6.8207 |
Length (AA): 570 |
MW (Da): 63100 |
Paralog Number:
6
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 4 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
46 | 480 | 2oh2 (B) | 21 | 513 | 34.00 | 0 | 1 | 1.06496 | 0.06 |
78 | 133 | 5hmo (A) | 814 | 869 | 23.00 | 0.96 | 0.01 | 0.434246 | -1.26 |
136 | 460 | 5c5j (F) | 5 | 321 | 36.00 | 0 | 1 | 0.879575 | 0.62 |
311 | 346 | 3mab (A) | 6 | 41 | 28.00 | 0 | 0.96 | 0.447958 | -0.31 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_127393)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT1G49980 | DNA/RNA polymerases superfamily protein |
Brugia malayi | Bm1_37790 | polk-prov protein |
Caenorhabditis elegans | CELE_F22B7.6 | Protein POLK-1, isoform B |
Dictyostelium discoideum | DDB_G0287149 | UMUC-like DNA-repair protein |
Escherichia coli | b0231 | DNA polymerase IV |
Echinococcus granulosus | EgrG_000832500 | dna polymerase kappa |
Echinococcus multilocularis | EmuJ_000832500 | dna polymerase kappa |
Giardia lamblia | GL50803_16810 | DINP protein human, muc B family |
Homo sapiens | ENSG00000122008 | polymerase (DNA directed) kappa |
Leishmania braziliensis | LbrM.28.1580 | DNA polymerase kappa, putative,DNA polymerase IV, putative |
Leishmania braziliensis | LbrM.28.1570 | DNA polymerase kappa, putative |
Leishmania donovani | LdBPK_281540.1 | DNA polymerase kappa, putative |
Leishmania donovani | LdBPK_281530.1 | DNA polymerase kappa, putative |
Leishmania infantum | LinJ.28.1530 | DNA polymerase kappa, putative |
Leishmania infantum | LinJ.28.1540 | DNA polymerase kappa, putative,DNA polymerase IV, putative |
Leishmania major | LmjF.28.1420 | DNA polymerase kappa, putative,DNA polymerase IV, putative |
Leishmania major | LmjF.28.1410 | DNA polymerase kappa, putative |
Leishmania mexicana | LmxM.28.1410 | DNA polymerase kappa, putative |
Leishmania mexicana | LmxM.28.1420 | DNA polymerase kappa, putative,DNA polymerase IV, putative |
Loa Loa (eye worm) | LOAG_02290 | hypothetical protein |
Mus musculus | ENSMUSG00000021668 | polymerase (DNA directed), kappa |
Mycobacterium tuberculosis | Rv1537 | Probable DNA polymerase IV DinX (pol IV 1) (DNA nucleotidyltransferase (DNA-directed)) |
Mycobacterium tuberculosis | Rv3056 | Possible DNA-damage-inducible protein P DinP (DNA polymerase V) (pol IV 2) (DNA nucleotidyltransferase (DNA-directed)) |
Mycobacterium ulcerans | MUL_1535 | DNA polymerase IV |
Mycobacterium ulcerans | MUL_5028 | DNA polymerase IV |
Oryza sativa | 4333450 | Os03g0616300 |
Schistosoma japonicum | Sjp_0121940 | ko:K03511 DNA polymerase kappa subunit, putative |
Schmidtea mediterranea | mk4.024598.01 | |
Schmidtea mediterranea | mk4.025253.00 | |
Schmidtea mediterranea | mk4.036851.03 | DNA polymerase iota |
Schmidtea mediterranea | mk4.002814.01 | DNA polymerase kappa |
Schmidtea mediterranea | mk4.014952.00 | |
Schmidtea mediterranea | mk4.001540.00 | |
Schmidtea mediterranea | mk4.002814.00 | |
Trypanosoma brucei gambiense | Tbg972.11.9710 | DNA polymerase kappa, putative |
Trypanosoma brucei gambiense | Tbg972.11.9680 | DNA polymerase kappa, putative |
Trypanosoma brucei gambiense | Tbg972.11.9700 | DNA polymerase kappa, putative |
Trypanosoma brucei gambiense | Tbg972.11.9720 | DNA polymerase kappa, putative,DNA polymerase IV, putative |
Trypanosoma brucei gambiense | Tbg972.11.9690 | DNA polymerase kappa, putative |
Trypanosoma brucei gambiense | Tbg972.11.9670 | DNA polymerase kappa, putative,DNA polymerase IV, putative |
Trypanosoma brucei gambiense | Tbg972.11.9660 | DNA polymerase kappa, putative,DNA polymerase IV, putative |
Trypanosoma brucei | Tb11.v5.0764 | DNA polymerase kappa, putative |
Trypanosoma brucei | Tb11.v5.1050 | DNA polymerase kappa, putative |
Trypanosoma brucei | Tb927.11.8490 | DNA polymerase kappa, putative |
Trypanosoma brucei | Tb11.v5.0661 | DNA polymerase kappa, putative |
Trypanosoma brucei | Tb11.v5.0526 | DNA polymerase kappa, putative |
Trypanosoma brucei | Tb11.v5.0711 | DNA polymerase kappa, putative |
Trypanosoma brucei | Tb927.11.8510 | DNA polymerase kappa, putative |
Trypanosoma brucei | Tb927.11.8480 | DNA polymerase kappa, putative |
Trypanosoma brucei | Tb427tmp.01.0010 | DNA polymerase IV, putative |
Trypanosoma brucei | Tb927.11.8680 | DNA polymerase kappa, putative |
Trypanosoma brucei | Tb11.v5.0756 | DNA polymerase kappa, putative |
Trypanosoma brucei | Tb427tmp.01.0030 | DNA polymerase IV, putative |
Trypanosoma brucei | Tb11.v5.0878 | DNA polymerase kappa, putative |
Trypanosoma brucei | Tb927.11.8500 | DNA polymerase kappa, putative |
Trypanosoma brucei | Tb11.v5.1058 | DNA polymerase kappa, putative |
Trypanosoma brucei | Tb11.v5.1056 | DNA polymerase kappa, putative |
Trypanosoma brucei | Tb927.11.8520 | DNA polymerase kappa, putative |
Trypanosoma congolense | TcIL3000_0_59930 | DNA polymerase kappa, putative |
Trypanosoma cruzi | TcCLB.503755.30 | DNA polymerase kappa, putative |
Trypanosoma cruzi | TcCLB.503755.10 | DNA polymerase kappa, putative |
Trypanosoma cruzi | TcCLB.510131.70 | DNA polymerase kappa, putative |
Trypanosoma cruzi | TcCLB.510131.50 | DNA polymerase kappa, putative |
Toxoplasma gondii | TGME49_237480 | BRCA1 C Terminus (BRCT) domain-containing protein |
Trichomonas vaginalis | TVAG_062670 | DNA polymerase IV / kappa, putative |
Trichomonas vaginalis | TVAG_177420 | DNA polymerase eta, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
mtu3109 | Mycobacterium tuberculosis | non-essential | nmpdr |
Tb11.12.0001 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (3 days) | alsford |
Tb11.12.0001 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb11.12.0001 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb11.12.0001 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
Tb11.12.0019 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb11.12.0019 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb11.12.0019 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb11.12.0019 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
Tb11.01.0010 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb11.01.0010 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb11.01.0010 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb11.01.0010 | Trypanosoma brucei | significant gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
b0231 | Escherichia coli | non-essential | goodall |
TGME49_237480 | Toxoplasma gondii | Essentiality uncertain | sidik |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Homo sapiens | polymerase (DNA directed) kappa | Compounds | References |